OIT 384: Biodesign Innovation: Needs Finding and Concept Creation
In this two-quarter course series ( OIT 384/5), multidisciplinary student teams identify real-world unmet healthcare needs, invent new medtech products to address them, and plan for their development into patient care. During the first quarter (winter 2017), students select and characterize an important unmet healthcare problem, validate it through primary interviews and secondary research, and then brainstorm and screen initial technology-based solutions. In the second quarter (spring 2017), teams select a lead solution and move it toward the market through prototyping, technical re-risking, strategies to address healthcare-specific requirements (regulation, reimbursement), and business planning. Final presentations in winter and spring are made to a panel of prominent medtech experts and investors. Class sessions include faculty-led instruction and case demonstrations, coaching sessions by industry specialists, expert guest lecturers, and interactive team meetings. Enrollment is by application only, and students are expected to participate in both quarters of the course. Visit http://biodesign.stanford.edu/programs/stanford-courses/biodesign-innovation.html to access the application, examples of past projects, and student testimonials. More information about Stanford Biodesign, which has led to the creation of more than 40 venture-backed healthcare companies and has helped hundreds of student launch health technology careers, can be found at http://biodesign.stanford.edu/.
Units: 4 | Grading: GSB Student Option LTR/PF
Instructors: Yock, P. (PI) ; Brinton, T. (SI) ; Denend, L. (SI) ; Venook, R. (SI) ; Watkins, F. (SI)
OIT 384 |
4 units |
Section 01 |
Grading: GSB Student Option LTR/PF |
| Students enrolled: 18
01/09/2017 - 03/17/2017 Tue, Thu 4:30 PM - 6:20 PM at GSB McClelland 104 with Yock, P. (PI); Brinton, T. (SI); Denend, L. (SI); Venook, R. (SI); Watkins, F. (SI)
Instructors: Yock, P. (PI); Brinton, T. (SI); Denend, L. (SI); Venook, R. (SI); Watkins, F. (SI)
Notes: No Exam. Workshop. Cross-listed as MED272A, ME374A, and BIOE374A. 2 Group Projects/Papers. Capacity limited to 50 students. Mandatory attendance. Absences impact grade. CSI certificate course. P/F Allowed. MBA and MSx students need instructor permission. Not Open to Non-GSB Students. Participation 10% Projects/Papers 60% Other 30%.
OIT 581: Biodesign Innovation: Needs Finding and Concept Creation
OIT581 is a two-unit version of the Biodesign Innovation course ( OIT384). In this course, students learn how to develop comprehensive solutions (most commonly medical devices) to some of the most significant medical problems. In OIT581, students learn the basic principles of biodesign innovation: methods of validating medical needs; techniques for analyzing intellectual property; basics of regulatory (FDA) and reimbursement planning; early market analysis; design principles; brainstorming and early prototyping; university licensing. Course format includes expert guest lecturers and faculty-led practical demonstrations. Students apply the concepts learned by serving as "commercialization and marketing consultants" to multidisciplinary teams of students in the four-unit course ( OIT 384). Consultants interact with their teams on a regular basis and provide a consulting report on market analysis and competitive dynamics. Projects from previous years included: prevention of hip fractures in the elderly; methods to accelerate healing after surgery; less invasive procedures to perform bariatric surgery; low cost healing devices for diabetic ulcers; point of care diagnostics to improve emergency room efficiency; novel devices to bring specialty-type of care to primary care community doctors. More than 40,000 patients have been treated to date with technologies developed as part of this program and more than ten venture-backed companies were started by alums of the program.nnnStudents must apply and be accepted into the course. The application is available online at http://www.stanford.edu/group/biodesign/courseapplication.html, and the application deadline is November 20, 2010. Students must indicate whether they are applying for the four-unit version ( OIT384) or two-unit version ( OIT581).
Units: 2 | Grading: GSB Letter Graded
OIT 583: Biodesign Innovation Core, Spring
Two quarter sequence (continuation of OIT581 -- see OIT 581 for a general description of the Biodesign Innovation course and OT384/385 for a description of the four unit option). The second quarter focuses on how to take a conceptual solution to an important medical need forward from early concept to technology translation, development and possible commercialization. Students expand on the topics they learned in OIT581 to learn about prototyping; patent strategies; advanced planning for reimbursement and FDA approval; choosing translation and commercialization route (licensing vs. start-up); marketing, sales and distribution strategies; ethical issues including conflict of interest; fundraising approaches and cash requirements; financial modeling; essentials of writing a business or research plan; strategies for assembling a development team. Students serve as "commercialization consultants" to a multidisciplinary team in OIT385. Students interact regularly with their team and prepare a consulting report that outlines a funding strategy and validates the financial model developed by the team. (OIT581 or OIT384 are a pre-requisite).nnnNew students (i.e. students who did not take OIT581/ OIT384) in the winter quarter will need to submit an application at http://www.stanford.edu/group/biodesign/courseapplication.html by Feburary 19, 2011. In the application they should indicate whether they are applying for the 2-unit or 4-unit version. Students who took OIT581/OIT384 in the winter quarter are automatically accepted into the spring quarter and they can choose the version they want: 2 unit or 4 unit.
Units: 2 | Grading: GSB Student Option LTR/PF